Trials / Completed
CompletedNCT03964168
An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Psoriasis Treatment Center of Central New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.
Detailed description
Retrospective chart review and patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider. This research intends to improve the continuity of care by determining why patients stop therapy and what can be done to improve their experience with the provider, pharmaceutical companies and specialty pharmacies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Biologic Agent | Patients who discontinued a bioloic agent |
Timeline
- Start date
- 2019-07-31
- Primary completion
- 2020-03-03
- Completion
- 2020-03-03
- First posted
- 2019-05-28
- Last updated
- 2020-03-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03964168. Inclusion in this directory is not an endorsement.